Skip to main content
. Author manuscript; available in PMC: 2016 Jun 15.
Published in final edited form as: Clin Cancer Res. 2015 Mar 16;21(12):2820–2829. doi: 10.1158/1078-0432.CCR-14-3322

Figure 4.

Figure 4

Kaplan-Meier analysis of CTCL patient disease outcomes A. CTCL patient overall disease progression (defined as progression to a higher clinical stage and/or death, p=0.005) B. CTCL patient disease-specific survival, p=0.034 C. Progression of patients with stage I disease to more advance stages (i.e., stage ≥II). D. p-Values for Kaplan-Meier comparisons for each individual cluster pair.